Eliminating need to dilate

Article

Faster technology to be able to screen for diabetic retinopathy is a requirement as the disease is becoming more prevalent.

Faster technology to be able to screen for diabetic retinopathy is a requirement as the disease is becoming more prevalent. A new retinal imaging system has been confirmed to match or outperform fundus cameras in a recent clinical trial.

The DRIVE trial looked at 100 people with diabetes and examined the efficacy of the EasyScan (i-Optics). The performance of the system was assessed head-to-head with a fundus camera in the early diagnosis of diabetic retinopathy.

It was shown that the non-mydriatic confocal SLO technology successfully scanned all 100 patients without pharmacological dilation. Additionally, a large portion of the study group could be imaged in under 3 minutes. The results of this trial will be featured in ARVO and will add to the results of an earlier trial of the system’s imaging performance.

One of the first doctors to use the system in the US Dr Steven Squillace gave his opinion on the system. "I've worked with SLO technology for retinal evaluation over 10 years ago as part of a group practice. We saw the benefit of undilated fundus images, but also the drawback… When I heard there was a smaller version being launched, I thought it could be what I needed."

Dr Squillace has used the technology on over 100 patients and now states that he uses it exclusively for routine check ups.

If you would like to read more about the EasyScan the full article can be found in the May print issue of OTEurope.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.